// Press Release

April 29th, 2021

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury TORONTO, April 27, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce … Continue reading Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury

April 29th, 2021

Memoir Details Author’s Journey with Mental Illness and Disability

Memoir Details Author’s Journey with Mental Illness and Disability Long Island, NY, April 27, 2021 – As we enter Mental Health Awareness month, one author and artist is sharing her coming-of-age story through the lenses of mental illness, disability and steadfast determination. Long Island native Ruth Poniarski’s first book, Journey of the Self: Memoir of an Artist, … Continue reading Memoir Details Author’s Journey with Mental Illness and Disability

April 29th, 2021

Roasted Bean Box Launches World’s First Data-driven Coffee Subscription in Montreal

Roasted Bean Box Launches World’s First Data-driven Coffee Subscription in Montreal Coffee lovers can get the flavors of the world customized to their exact taste preferences and delivered right to their door with Roasted Bean Box’s new subscription service. MONTREAL, April 27, 2021 (GLOBE NEWSWIRE) — Roasted Bean Box, a hot new subscription coffee delivery … Continue reading Roasted Bean Box Launches World’s First Data-driven Coffee Subscription in Montreal

April 29th, 2021

AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer

AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer Health Canada Approval Enables Quick and Accurate Blood Testing TORONTO, April 27, 2021 /CNW/ – AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed … Continue reading AA Pharma Strengthens its Support of Canadian Clozapine Patients With Exclusive Rights to Blood Analyzer

April 29th, 2021

Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel)

Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel) Expansion of treatment centre network includes two specialized centres in Alberta certified to deliver Kymriah to Canadian patients with relapsed/refractory (r/r) pediatric and young adult B-cell ALL and adult r/r DLBCL Alberta joins Quebec and Ontario to reimburse Kymriah therapy for these life-threatening … Continue reading Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel)

April 29th, 2021

Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes

Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes TTI-622 monotherapy shows 33% objective response rate (ORR) in relapsed/refractory (R/R) lymphomas at 0.8-18 mg/kg doses, including 3 new responses (1 Complete Response (CR) + 2 Partial Responses (PRs)) since last data disclosure; TTI-621 monotherapy … Continue reading Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes

April 29th, 2021

Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has dosed the first multiple … Continue reading Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

April 29th, 2021

Syqe Medical® Receives Health Canada Approval for the First-Ever Medical Cannabis Delivery Device with Predictable, Consistent Dosing

Syqe Medical® Receives Health Canada Approval for the First-Ever Medical Cannabis Delivery Device with Predictable, Consistent Dosing The novel Syqe® Inhaler with its precision dosing helps relieve symptoms with lower risk of adverse reactions TORONTO, April 28, 2021 /CNW/ – Syqe Medical®, a leading global pharma-tech company, announces today that Health Canada has approved the Syqe® Inhaler, the … Continue reading Syqe Medical® Receives Health Canada Approval for the First-Ever Medical Cannabis Delivery Device with Predictable, Consistent Dosing

April 29th, 2021

Marigold PR Announces Agenda and Expert-Driven Lineup for Second Annual Womxn, Wellness, and Cannabis Conference

Marigold PR Announces Agenda and Expert-Driven Lineup for Second Annual Womxn, Wellness, and Cannabis Conference Toronto, ON, April 28, 2021 (GLOBE NEWSWIRE) — Award-winning cannabis marketing and PR firm, Marigold PR, today announced the agenda for its second annual Womxn, Wellness and Cannabis Conference (WWC Conference) on May 26-27, 2021.  Hosted in celebration of the feminine cannabis and psychedelic experience, … Continue reading Marigold PR Announces Agenda and Expert-Driven Lineup for Second Annual Womxn, Wellness, and Cannabis Conference

April 29th, 2021

You Can TRUST Him When Your Life is Spinning Out of Control

You Can TRUST Him When Your Life is Spinning Out of Control Houston, TX, April 27, 2021 — The disruption and difficulties of 2020 also uprooted our time with the Lord when churches closed their doors and our daily routines changed dramatically. Many people lost their jobs or lost their loved ones, despite praying diligently for different … Continue reading You Can TRUST Him When Your Life is Spinning Out of Control

TRAIN IT RIGHT NEWSLETTER

Sign Up and get a free 7 day Train it Right HIIT Program!

Top
WP Twitter Auto Publish Powered By : XYZScripts.com